Tanabe Kenji, Torii Tetsuo, Natsume Waka, Braesch-Andersen Sten, Watanabe Toshio, Satake Masanobu
Department of Molecular Immunology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan.
Mol Biol Cell. 2005 Apr;16(4):1617-28. doi: 10.1091/mbc.e04-08-0683. Epub 2005 Jan 19.
ADP-ribosylation factor 6 (Arf6) is a small-GTPase that regulates the membrane trafficking between the plasma membrane and endosome. It is also involved in the reorganization of the actin cytoskeleton. GTPase-activating protein (GAP) is a critical regulator of Arf function as it inactivates Arf. Here, we identified a novel species of GAP denoted as SMAP1 that preferentially acts on Arf6. Although overexpression of SMAP1 did not alter the subcellular distribution of the actin cytoskeleton, it did block the endocytosis of transferrin receptors. Knock down of endogenous SMAP1 also abolished transferrin internalization, which confirms that SMAP1 is needed for this endocytic process. SMAP1 overexpression had no effect on clathrin-independent endocytosis, however. Intriguingly, SMAP1 binds directly to the clathrin heavy chain via its clathrin-box and mutation studies revealed that its GAP domain and clathrin-box both contribute to the role SMAP1 plays in clathrin-dependent endocytosis. These observations suggest that SMAP1 may be an Arf6GAP that specifically regulates one of the multiple functions of Arf6, namely, clathrin-dependent endocytosis, and that it does so by binding directly to clathrin.
ADP核糖基化因子6(Arf6)是一种小GTP酶,可调节质膜和内体之间的膜运输。它还参与肌动蛋白细胞骨架的重组。GTP酶激活蛋白(GAP)是Arf功能的关键调节因子,因为它使Arf失活。在这里,我们鉴定了一种新的GAP,命名为SMAP1,它优先作用于Arf6。虽然SMAP1的过表达没有改变肌动蛋白细胞骨架的亚细胞分布,但它确实阻断了转铁蛋白受体的内吞作用。敲低内源性SMAP1也消除了转铁蛋白的内化,这证实了SMAP1是这种内吞过程所必需的。然而,SMAP1的过表达对网格蛋白非依赖性内吞作用没有影响。有趣的是,SMAP1通过其网格蛋白盒直接与网格蛋白重链结合,突变研究表明其GAP结构域和网格蛋白盒都有助于SMAP1在网格蛋白依赖性内吞作用中发挥的作用。这些观察结果表明,SMAP1可能是一种Arf6GAP,它特异性调节Arf6的多种功能之一,即网格蛋白依赖性内吞作用,并且它通过直接与网格蛋白结合来实现这一点。